The role of Complex Lipids in Attaining Metabolic Health

Current Cardiovascular Risk Reports

Volumn 8, Issue 1, 2014, Pages 1-8

  Rueda, Ricardo ^a  

^a ABBOTT LABORATORIES   (Spain)

Author keywords

Atherosclerosis; Cardiovascular disease; Cholesterol; Complex lipids; Coronary heart disease; Diabetes; Dyslipidemias; Gangliosides; Glycerophospholipids; Glycospingolipids; Metabolic health; Milk fat globule membrane (MFGM); Obesity; Phospholipids; Sphingolipids

Indexed keywords

CHOLESTEROL; COMPLEX LIPID; CRYOPYRIN; FAT DROPLET; GLUCOSYLCERAMIDE; GLYCEROPHOSPHOLIPID; GLYCOSPHINGOLIPID; LACTOSYLCERAMIDE; LIPID; MILK FAT; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROTEIN KINASE B; SPHINGOLIPID; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; INTESTINE FLORA; ISCHEMIC HEART DISEASE; LACTATION; LIPID METABOLISM; METABOLIC DISORDER; METABOLISM; MILK; MILK FAT GLOBULE MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

EID: 84894028189     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-013-0371-4     Document Type: Review

References (49)

1. Patton S, Keenan TW. The milk fat globule membrane. Biochim Biophys Acta. 1975;415: 273-309.
2. Cavaletto M, Giuffrida MG, Contib A. The proteomic approach to analysis of human milk fat globule membrane. Clin Chim Acta. 2004;347: 41-8.
3. Spitsberg VL. Invited review: Bovine milk fat globule membrane as a potential nutraceutical. J Dairy Sci. 2005;88: 2289-94. Relatively recent review on the health beneficial effects derived from bovine MFGM, including those related to metabolic health.
4. Contarini G, Povolo M. Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies. Int J Mol Sci. 2013;14: 2808-31. Very recent review on the role of phospholipids from milk fat on both the nutritional and technological fields.
5. Howard AN, Marks J. Effect of milk products on serum-cholesterol. Lancet. 1979;2(8149): 957.
6. Ito O, Kamata M, Hayashi Y, et al. Inhibitory Effect of Cream and Milk Fat Globule Membrane Substances on Hypercholesterolemia in the Rat. Anim Sci Technol. 1992;63: 1022-7.
7. Warensjö E, Jansson JH, Berglund L, et al. Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case-control study. Br J Nutr. 2004;91: 635-42.
8. Moss M, Freed D. The cow and the coronary: epidemiology, biochemistry and immunology. Int J Cardiol. 2003;87: 203-16.
9. Michalski MC. On the supposed influence of milk homogenization on the risk of CVD, diabetes and allergy. Br J Nutr. 2007;97: 598-610.
10. Mesilati-Stahy R, Argov-Argaman N. The relationship between size and lipid composition of the bovine milk fat globule is modulated by lactation stage. Food Chem. 2014;145: 562-70.
11. Le TT et al. Stability of milk fat globule membrane proteins toward human enzymatic gastrointestinal digestion. J Dairy Sci. 2012;95: 2307-18.
12. Tholstrup T. Dairy products and cardiovascular disease. Curr Opin Lipidol. 2006;17: 1-10.
13. Gibson RA, Makrides M, Smithers LG, et al. The effect of dairy foods on CHD: a systematic review of prospective cohort studies. Br J Nutr. 2009;102: 1267-75.
14. Conway V, Couture P, Richard C, et al. Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women. Nutr Metab Cardiovasc Dis. 2013: ii. Very recent clinical study demostrating that consumption of buttermilk (mainly MFGM sphingolipids) is associated with reduced cholesterol concentrations, primarily through inhibition of intestinal absorption of cholesterol.
15. Bel-Serrat S et al. Is dairy consumption associated with low cardiovascular disease risk in European adolescents? Results from the HELENA Study. Pediatr Obes. 2013. doi: 10. 1111/j. 2047-6310. 2013. 00187. x.
16. De Oliveira Otto MC et al. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2013;2: e000092.
17. Benatar JR et al. Effects of high and low fat dairy food on cardio-metabolic risk factors: a meta-analysis of randomized studies. PLoS One. 2013;8: e76480.
18. Wang et al. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond). 2013.
19. Balgoma D, Checa A, Sar DG, et al. Quantitative metabolic profiling of lipid mediators. Mol Nutr Food Res. 2013;57: 1359-77.
20. Wat E, Tandy S, Kapera E, et al. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis. 2009;205: 144-50.
21. Watanabe S, Takahashi T, Tanaka L, et al. The effect of milk polar lipids separated from butter serum on the lipid levels in the liver and the plasma of obese-model mouse (KK-Ay). J Funct Foods. 2011;3: 313-20.
22. Ohlsson L, Burling H, Duan R-D, et al. Effects of a sphingolipid-enriched dairy formulation on postprandial lipid concentrations. Eur J Clin Nutr. 2010;64: 1344-9.
23. Ohlsson L, Burling H, Nilsson A. Long term effects on human plasma lipoproteins of a formulation entiched in butter milk polar lipid. Lipids Health Dis. 2009;8: 44.
24. Keller S, Malarski A, Reuther C, et al. Milk phospholipid and plant sterol-dependent modulation of plasma lipids in healthy volunteers. Eur J Nutr. 2013;52: 1169-79.
25. Mallat Z, Lambeau G, Tedgui A. Lipoprotein-associated and secreted phospholipases a2 in cardiovascular disease: Roles as biological effectors and biomarkers. Circulation. 2010;122: 2183-200.
26. Noh SK, Koo SI. Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. J Nutr. 2004;134: 2611-6.
27. Kamili A, Wat E, Chung RWS, et al. Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutr Metab. 2010;7: 90-101.
28. Harder T, Simons K. Caveolae, DIGs, and the dynamics of sphingolipid cholesterol microdomains. CurrOpin Cell Biol. 1997;9: 534-42.
29. Messner MC, Cabot MC. Glucosylceramide in humans. Adv Exp Med Biol. 2010;688: 156-64.
30. Mukhin DN, Chao FF, Kruth HS. Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15: 1607-15.
31. Chatterjee SB, Dey S, Shi WY, et al. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology. 1997;7: 57-65.
32. Langeveld M, Aerts JM. Glycosphingolipids and insulin resistance. Prog Lipid Res. 2009;48: 196-205.
33. Yamamoto N, Matsubara T, Sobue K, et al. Brain insulin resistance accelerates Aβ fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes. J Neurochem. 2012;121: 619-28.
34. Yaqoob P, Shaik SR. The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care. 2010;13: 156-66. Review focused on the role of n-3 PUFAs, cholesterol and gangliosides modulating the structure and composition of lipid rafts and potentially influencing, as a consequence, a wide range of biological processes.
35. Owen CG, Whincup PH, Kaye SJ, et al. Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr. 2008;88: 305-14.
36. Owen CG, Whincup PH, Odoki K, et al. Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics. 2002;110: 597-608.
37. Demmers TA, Jones PJ, Wang Y, et al. Effects of early cholesterol intake on cholesterol biosynthesis and plasma lipids among infants until 18 months of age. Pediatrics. 2005;115: 1594-601.
38. Harris JR, Milton NG. Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcell Biochem. 2010;51: 47-75.
39. Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast. 2005;12: 311-28.
40. Ouimet M. Autophagy in obesity and atherosclerosis: Interrelationships between cholesterol homeostasis, lipoprotein metabolism and autophagy in macrophages and other systems. Biochim Biophys Acta. 1831;2013: 1124-33.
41. Sheedy FJ, Grebe A, Rayner KJ, et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol. 2013;14: 812-20.
42. Kagan JC, Horng T. NLRP3 inflammasome activation: CD36 serves double duty. Nat Immunol. 2013;14: 772-4.
43. Xiao C, Hsieh J, Adeli K, et al. Gut-liver interaction in triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab. 2011;301: E429-46.
44. White RA, Bjørnholt JV, Baird DD, et al. Novel developmental analyses identify longitudinal patterns of early gut microbiota that affect infant growth. PLoS Comput Biol. 2013;9: e1003042. Recent study describing new methodological and biological findings relating microbiota and infant growth.
45. O'Sullivan A, He X, McNiven EM, et al. Early diet impacts infant rhesus gut microbiome, immunity, and metabolism. J Proteome Res. 2013;12: 2833-45. Recent study describing that metabolic and gut microbiome development of formula-fed infants is different from breast-fed infants.
46. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500: 541-6. Very recent study describing on association between richness and variation in the gut microbiome and risk of adiposity and associated co-morbidities.
47. Rueda R. Role of dietary gangliosides on prevention of infection and immunity. Br J Nutr. 2007;98 Suppl 1: S68-73.
48. Ramirez M, Vazquez E, Jimenez ML, et al. Effect of prototype formulas enriched in sialic acid, gangliosides and phospholipids, and containing fructooligosaccharides on diarrhea and feeding tolerance in piglets. WCPGHAN. 2008: 189-194.
49. Yoshimoto S et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456): 97-101.